DYRK2 and ovarian cancer: In this regard, DYRK2 phosphorylates the EMT transcription factor Snail, priming it for ubiquitination-mediated degradation [141] (Figure 5A), which provides additional evidence that DYRK2 prevents the activation of aggressive phenotypes in breast and ovarian cancer cells.